Inflammation

Two recent studies add significant evidence toward understanding the cause of MS

The finding will likely help physicians develop targeted therapies for future COVID-19 patients

Researchers examine why one in 1,000 children with COVID-19 experience multisystem inflammatory response

Study examines the key differences between severe inflammation in COVID-19 vs cytokine storm

How T cells in the small intestine protect themselves from bile acids point to the possibility of targeted treatments for Crohn's

Join Clinical Lab Manager and our panel of experts as we discuss how high-plex automated immunoassays facilitate critical discoveries in immune medicine, accelerating the development of advanced therapeutics across disciplines

Researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems' responses

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

Partnership combines molecular patient data, AI-based methods to identify novel targets and pathways